Clinical Trial of TJ0113 Capsules in the Treatment of Patients With Depressive Disorder

PHASE2RecruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

July 9, 2025

Primary Completion Date

May 25, 2026

Study Completion Date

September 1, 2026

Conditions

Depression

Interventions

DRUG

TJ0113

200 mg or 400 mg Capsule, Once Daily

DRUG

Placebo

Capsule, Once Daily

Trial Locations (1)

RECRUITING

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors

lead

Hangzhou PhecdaMed Co., Ltd.

INDUSTRY

NCT07018245 - Clinical Trial of TJ0113 Capsules in the Treatment of Patients With Depressive Disorder | Biotech Hunter | Biotech Hunter